AdvaMed Answers Scully On Cost Effectiveness Role In Medicare Coverage
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed maintains that CMS consideration of cost-effectiveness would bias Medicare coverage decisions against technologies early in a product's lifecycle